Latest / PETRI DISH PERSPECTIVES
Episode 8: Bristol Myers Squibb
Send us Fan Mail
In this episode of Petri Dish Perspectives: Biotech Unleashed, we journey through the 165+ year saga of Bristol Myers Squibb (BMS) — from 19th-century Brooklyn apothecaries and sparkling laxatives 💊 to cutting-edge CAR-T therapies and checkpoint inhibitors in cancer treatment 🧫🔥.
Host Manead, a PhD scientist in cancer biology and analytical chemistry, breaks down:
📜 The parallel founding stories of E.R. Squibb & Sons and Bristol-Myers
🧠 The game-changing 1989 merger that created BMS
❤️ Blockbuster hits in cardiovascular health (Plavix, anyone?)
🧪 The leap into immuno-oncology…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.